Avalo 制药 AVTX
$6.93 +$0.30 (+4.52%)
休市 · Nov 6, 8:10 pm ET · 最新盘后价 $7.05 +1.73%
开盘$6.90
昨收$6.63
当日区间$6.53 – $7.01
成交量1.11M
市值$400.71M
市盈率（TTM）–
股息率–
基本面
最新报告季度：Q2, ended Jun 2026
营收$0.00
营业利润-$31.52M-63.2% YoY
净利润-$36.36M-75.1% YoY
摊薄每股收益-$0.83+56.8% YoY
自由现金流-$19.99M-75.5% YoY
经营现金流-$19.99M
营收，近8个季度
净利润，近8个季度
各季度摊薄每股收益
各季度自由现金流
年度营收
盈利能力与资产负债表
营业利润率-154,847.5%
净利率-170,055.9%
净资产收益率-36.3%
资产收益率-32.5%
投入资本回报率-36.2%
流动比率19.31
负债/资产比率8.6%
现金及投资$400.28M
总负债$0.00
净现金（净负债）$400.28M
利润表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| 营业总收入 | $0.00 | $0.00 | $59,000.00 | $59,000.00 | $0.00 |
| 营业费用 | $31.52M | $20.90M | $72.98M | $19.80M | $19.20M |
| 销售及管理费用 | $8.10M | $6.85M | $22.90M | $6.53M | $5.58M |
| -销售及营销费用 | $126,000.00 | $209,000.00 | $470,000.00 | $381,000.00 | $22,000.00 |
| -管理费用 | $7.97M | $6.65M | $22.43M | $6.15M | $5.56M |
| 研发费用 | $23.42M | $14.05M | $50.08M | $13.27M | $13.62M |
| 营业利润 | -$31.52M | -$20.90M | -$72.93M | -$19.74M | -$19.20M |
| 非经营性利息净收入（支出） | $2.76M | $803,000.00 | $4.35M | $984,000.00 | $1.12M |
| 非经营性利息收入 | $2.76M | $803,000.00 | – | – | $1.12M |
| 其他收入（支出） | -$7.58M | $480,000.00 | -$9.52M | $5.17M | -$12.53M |
| 证券出售收益 | -$1.01M | $480,000.00 | -$9.52M | $5.16M | -$12.53M |
| 特殊收益（费用） | -$6.57M | – | $0.00 | $0.00 | $0.00 |
| -减：重组及并购费用 | $6.57M | – | $0.00 | – | – |
| 税前利润 | -$36.34M | -$19.62M | -$78.09M | -$13.59M | -$30.61M |
| 税费 | $18,000.00 | $12,000.00 | $165,000.00 | $130,000.00 | $11,000.00 |
| 净利润 | -$36.36M | -$19.63M | -$78.26M | -$13.72M | -$30.63M |
| 持续经营利润 | -$36.36M | -$19.63M | -$78.26M | -$13.72M | -$30.63M |
| 归属母公司净利润 | -$36.36M | -$19.63M | -$78.26M | -$13.72M | -$30.63M |
| 归属普通股股东净利润 | -$36.36M | -$19.63M | -$78.26M | -$13.72M | -$30.63M |
| 基本每股收益 | -$0.83 | -$0.98 | -$5.84 | -$0.37 | -$2.19 |
| 摊薄每股收益 | -$0.83 | -$0.98 | -$5.84 | -$0.37 | -$2.19 |
| 报告营业总收入 | – | – | $59,000.00 | $59,000.00 | $0.00 |
| 营业成本 | – | – | $0.00 | $0.00 | $0.00 |
| 毛利润 | – | – | $59,000.00 | $59,000.00 | $0.00 |
| 其他财务成本合计 | – | – | -$4.35M | – | – |
| 其他非经营性收入（支出） | – | – | – | – | -$3,000.00 |
资产负债表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| 总资产 | $490.78M | $99.89M | $116.46M | $116.46M | $125.10M |
| 流动资产合计 | $407.93M | $88.83M | $105.29M | $105.29M | $113.85M |
| 现金及现金等价物与短期投资 | $400.28M | $81.99M | $98.34M | $98.34M | $111.62M |
| -现金及现金等价物 | $85.38M | $24.99M | $15.86M | $15.86M | $26.96M |
| -短期投资 | $314.89M | $57.01M | $82.48M | $82.48M | $84.65M |
| 受限现金 | $49,000.00 | $147,000.00 | $37,000.00 | $37,000.00 | $90,000.00 |
| 其他流动资产 | $7.61M | $6.69M | $6.91M | $6.91M | $2.14M |
| 非流动资产合计 | $82.85M | $11.06M | $11.17M | $11.17M | $11.25M |
| 固定资产净值 | $288,000.00 | $375,000.00 | $460,000.00 | $460,000.00 | $542,000.00 |
| 投资及预付款 | $71.88M | – | – | – | – |
| 商誉及其他无形资产 | $10.50M | $10.50M | $10.50M | $10.50M | $10.50M |
| -商誉 | $10.50M | $10.50M | $10.50M | $10.50M | $10.50M |
| 其他非流动资产 | $183,000.00 | $183,000.00 | $210,000.00 | $210,000.00 | $210,000.00 |
| 负债合计 | $42.12M | $31.57M | $33.41M | $33.41M | $33.55M |
| 流动负债合计 | $21.13M | $11.60M | $12.94M | $12.94M | $7.97M |
| 应付款 | $3.35M | $683,000.00 | $464,000.00 | $464,000.00 | $801,000.00 |
| -应付账款 | $3.35M | $356,000.00 | $137,000.00 | $137,000.00 | $474,000.00 |
| 一年内应计费用 | $14.74M | $8.84M | $7.95M | $7.95M | $3.35M |
| 短期债务及融资租赁负债 | $242,000.00 | $328,000.00 | $392,000.00 | $392,000.00 | $438,000.00 |
| -一年内到期融资租赁负债 | $242,000.00 | $328,000.00 | $392,000.00 | $392,000.00 | $438,000.00 |
| 非流动负债合计 | $20.99M | $19.97M | $20.47M | $20.47M | $25.58M |
| 长期债务及融资租赁负债 | $0.00 | $0.00 | – | – | $117,000.00 |
| -长期融资租赁负债 | $0.00 | $0.00 | – | – | $117,000.00 |
| 衍生产品负债 | $18.53M | $17.52M | $18.00M | $18.00M | $23.16M |
| 一年以上递延负债 | $463,000.00 | $446,000.00 | $434,000.00 | $434,000.00 | $304,000.00 |
| 可转换优先证券 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| 其他非流动负债 | $2.00M | $2.00M | $2.04M | $2.04M | $2.00M |
| 股东权益合计 | $448.66M | $68.32M | $83.05M | $83.05M | $91.55M |
| 股东权益 | $448.66M | $68.32M | $83.05M | $83.05M | $91.55M |
| 股本 | $53,000.00 | $25,000.00 | $18,000.00 | $18,000.00 | $18,000.00 |
| -普通股 | $53,000.00 | $25,000.00 | $18,000.00 | $18,000.00 | $18,000.00 |
| -优先股 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| 资本公积 | $953.70M | $536.45M | $531.49M | $531.49M | $526.29M |
| 留存收益 | -$504.51M | -$468.15M | -$448.52M | -$448.52M | -$434.80M |
| 不影响留存收益的损益 | -$583,000.00 | -$6,000.00 | $68,000.00 | $68,000.00 | $41,000.00 |
| -其他应付款 | – | $327,000.00 | $327,000.00 | $327,000.00 | $327,000.00 |
| -固定资产原值 | – | – | $713,000.00 | $713,000.00 | – |
| -累计折旧 | – | – | -$253,000.00 | -$253,000.00 | – |
现金流量表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| 经营活动现金流 | -$19.99M | -$17.69M | -$51.46M | -$14.25M | -$16.37M |
| 持续经营经营活动现金流净额 | -$19.99M | -$17.69M | -$51.46M | -$14.25M | -$16.37M |
| 持续经营净利润 | -$36.36M | -$19.63M | -$78.26M | -$13.72M | -$30.63M |
| 持续经营损益 | $1.01M | -$480,000.00 | $9.52M | -$5.16M | $12.53M |
| 折旧、折耗与摊销 | $17,000.00 | $17,000.00 | $344,000.00 | $16,000.00 | $59,000.00 |
| 递延税款 | $17,000.00 | $12,000.00 | $165,000.00 | $131,000.00 | $10,000.00 |
| 其他非现金项目 | $1.87M | -$106,000.00 | -$690,000.00 | – | – |
| 营运资金变动 | $8.68M | -$1.08M | $3.84M | $176,000.00 | -$1.15M |
| -预付资产变动 | -$922,000.00 | $228,000.00 | -$2.59M | -$4.77M | -$236,000.00 |
| -应付账款及应计费用变动 | $9.62M | -$1.28M | $6.52M | $5.01M | -$872,000.00 |
| -其他流动负债变动 | -$16,000.00 | -$31,000.00 | -$87,000.00 | -$63,000.00 | -$38,000.00 |
| 投资活动现金流净额 | -$329.93M | $25.51M | -$81.72M | $2.40M | -$13.26M |
| 持续经营投资活动现金流净额 | -$329.93M | $25.51M | -$81.72M | $2.40M | -$13.26M |
| 投资购置及出售净额 | -$329.93M | $25.51M | -$81.72M | $2.40M | -$13.26M |
| 筹资活动现金流 | $410.21M | $1.40M | $14.59M | $687,000.00 | $14.37M |
| 持续经营筹资活动现金流净额 | $410.21M | $1.40M | $14.59M | $687,000.00 | $14.37M |
| 股票期权行使所得 | $5.30M | $2.18M | $797,000.00 | $757,000.00 | $0.00 |
| 其他筹资费用净额 | -$26.40M | -$779,000.00 | -$972,000.00 | -$462,000.00 | -$1,000.00 |
| 期末现金余额 | $85.61M | $25.32M | $16.11M | $16.11M | $27.26M |
| 现金净变动 | $60.30M | $9.21M | -$118.59M | -$11.16M | -$15.26M |
| 期初现金余额 | $25.32M | $16.11M | $134.70M | $27.26M | $42.52M |
| 自由现金流 | -$19.99M | -$17.69M | -$51.46M | -$14.25M | -$16.37M |
| -应收款变动 | – | – | $0.00 | – | – |
| 业务购买及出售净额 | – | – | $0.00 | $0.00 | – |
| 普通股发行净额 | – | – | $14.76M | $392,000.00 | $14.37M |
暂无评论——快来第一个聊聊 AVTX。